Holen Sie sich die Stockscreener-App
54.53
2.09%
-1.205
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$55.74
Offen:
$55.55
24-Stunden-Volumen:
494.58K
Relative Volume:
0.21
Marktkapitalisierung:
$8.34B
Einnahmen:
$700.35M
Nettoeinkommen (Verlust:
$461.90M
KGV:
19.00
EPS:
2.8696
Netto-Cashflow:
$-14.19M
1W Leistung:
-4.09%
1M Leistung:
+9.68%
6M Leistung:
+86.96%
1J Leistung:
+70.55%
1-Tages-Spanne:
$54.43
$57.14
1-Wochen-Bereich:
$54.09
$58.47
52-Wochen-Spanne:
$26.76
$59.30
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
54.51 | 8.53B | 700.35M | 461.90M | -14.19M | 2.8696 |
VRTX
Vertex Pharmaceuticals Inc
|
521.01 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.07 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.98 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.12 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2024-10-29 | Eingeleitet | TD Cowen | Buy |
| 2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-26 | Fortgesetzt | Jefferies | Buy |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
| 2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-04-25 | Eingeleitet | Jefferies | Buy |
| 2017-03-06 | Bestätigt | FBR & Co. | Outperform |
| 2016-10-06 | Fortgesetzt | Brean Capital | Buy |
| 2016-05-27 | Eingeleitet | SunTrust | Buy |
| 2015-12-01 | Eingeleitet | FBR Capital | Outperform |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-19 | Bestätigt | Brean Capital | Buy |
| 2014-12-11 | Bestätigt | ROTH Capital | Buy |
| 2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - The Manila Times
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo
TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $78 - GuruFocus
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78 - Moomoo
TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors - DirectorsTalk Interviews
Price to book forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
TG Therapeutics (TGTX) Is Up 6.5% After Lifting 2026 Revenue Guidance on BRIUMVI Momentum - Sahm
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions - DirectorsTalk Interviews
TGTX Rallies As TG Therapeutics Hikes 2026 Revenue Outlook - timothysykes.com
TG Therapeutics (TGTX) Stock Still Looks Cheap Even After Strong Returns - Sahm
TG Therapeutics Stock Jumps As Guidance Hike Fuels Takeover Buzz - timothysykes.com
TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics - Yahoo Finance
TG Therapeutics Stock Jumps as Investors Reassess Growth Outlook - Quiver Quantitative
TGTX Stock Whipsaws As BRIUMVI Growth Fuels Bold 2026 Outlook - StocksToTrade
TGTX Stock Whipsaws As Guidance Jumps And EPS Miss Hits - timothysykes.com
TG Therapeutics (TGTX) Shares Surge 7.2% Amid Acquisition Rumors, Valuation Remains a Key Focus - GuruFocus
TG Therapeutics (TGTX) Stock Climbs 4% Amid Positive Market Sent - GuruFocus
Speculation on TG Therapeutics (TGTX) Acquisition Sparks Valuati - GuruFocus
Why is TG Therapeutics stock rallying today? By Investing.com - Investing.com Canada
Price to book forward of TG Therapeutics, Inc. – BX:NKB2 - TradingView
Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth with a Breakout Setup - ChartMill
TGTX Stock Jumps 5% On Positive Early Data For At-Home BRIUMVI In Muscle Disease - Stocktwits
TGTX Stock Rises 29% in 3 Months: Here's What You Should Know - qz.com
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection - TradingView
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a Potential 43% Upside in the Biotech Sector - DirectorsTalk Interviews
How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story - Sahm
US High Growth Tech Stocks To Watch: 3 Top Picks - Sahm
TGTX Stock Slips After Earnings – But CEO's $1B Briumvi Outlook Keeps Retail Bullish - Stocktwits
Trading Systems Reacting to (TGTX) Volatility - Stock Traders Daily
Bank of America Corp DE Purchases 610,195 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished - AOL.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - finance.yahoo.com
TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript - AOL.com
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):